Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Suchman

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The American Journal of Gastroenterology|September 17, 2021
Gastroenterology Clinical Trials Transparency: An Analysis of Publication Rates From the ClinicalTrials.gov DatabaseShashank Garg, Anam Rizvi, Diana Wee, et al.
Pancreas|April 20, 2023
A Comparison of Etiologies and Characteristics of Solitary Versus Synchronous Pancreatic Masses Undergoing Endoscopic Ultrasound-Guided BiopsyIrving Levine, Kelly Suchman, Zankesh Patel, et al.
Oncology|August 23, 2021
Secondary Invasive Breast Events among Patients with Hormone-Positive Breast Cancer and High-Risk Oncotype DX Recurrence Scores 26-30 and ≥31Natalie F Berger, Brittney S Zimmerman, Serena Tharakan, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The American Journal of Gastroenterology|September 17, 2021
Gastroenterology Clinical Trials Transparency: An Analysis of Publication Rates From the ClinicalTrials.gov DatabaseShashank Garg, Anam Rizvi, Diana Wee, et al.
Pancreas|April 20, 2023
A Comparison of Etiologies and Characteristics of Solitary Versus Synchronous Pancreatic Masses Undergoing Endoscopic Ultrasound-Guided BiopsyIrving Levine, Kelly Suchman, Zankesh Patel, et al.
Oncology|August 23, 2021
Secondary Invasive Breast Events among Patients with Hormone-Positive Breast Cancer and High-Risk Oncotype DX Recurrence Scores 26-30 and ≥31Natalie F Berger, Brittney S Zimmerman, Serena Tharakan, et al.
Pageof 2